The role of bronchodilator treatment in the prevention of exacerbations of COPD.
about
The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary diseaseAclidinium bromide for the treatment of chronic obstructive pulmonary diseaseBronchoscopic lung volume reduction procedures for chronic obstructive pulmonary diseaseGlycopyrronium bromide for chronic obstructive pulmonary diseaseMolecular Regulation of Toll-like Receptors in Asthma and COPDPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDClinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of lifeMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseUmeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a reviewThe Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary DiseaseEffect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosisPrevention of COPD exacerbations: medications and other controversiesWithdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Treatment evolution after COPD diagnosis in the UK primary care setting.COPD: maximization of bronchodilation.Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in SwedenCOPD: it is time to change!LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMACost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.Indacaterol: a comprehensive review.Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patientsHighly selective inhibition of myosin motors provides the basis of potential therapeutic applicationEffect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled StudiesClinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review.Defining phenotypes in COPD: an aid to personalized healthcare.Recent advances in COPD disease management with fixed-dose long-acting combination therapies.Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease.LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease.Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.The effects of bronchodilator drugs and antibiotics used for respiratory infection on human erythrocyte carbonic anhydrase I and II isozymes.Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.Dual bronchodilation and exacerbations of COPD.Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.The Challenges of Precision Medicine in COPD.
P2860
Q22305858-58D38235-D7D1-495D-8935-261082C092AAQ22306019-64E7AF90-AFD8-4743-8876-B679BF21D70FQ24185964-422C2797-96E9-4360-B647-1CFA0E48ED6CQ24197691-F24E17AC-2180-4217-BB01-15141F8D7971Q26776173-FE2CC753-2ED3-46F8-A3E3-C6F49AD17D43Q26778685-417F5A74-542D-43FA-83E6-5B9A87769893Q26801134-D67E1041-171A-4ED9-8CFF-3DBFABEAEC1BQ27000043-D32F71FD-F765-4D46-8729-5F7E9F13420AQ27015685-7825EB30-6253-4667-B2DC-FACBBD727851Q28068078-27215ECD-02EB-4C35-8BDA-2987349838C1Q28394883-2ADD7A77-9D90-467E-AC01-74CC32B3B6B0Q28596774-819F404B-56E7-447B-ABCA-463ABCE00818Q34003435-01AA26F0-E046-434F-B232-91B85D2B7332Q34121263-7FE042E9-C96E-4E1E-AEE9-C7E694099F62Q34436393-F251586E-102E-46C5-B786-4C65B918DB9BQ35964698-F27D506E-BA94-46F8-8AC2-BFB29346C211Q36288971-F575F567-5EA5-4934-BDB7-754A852393D6Q36329064-5CB8D33E-729E-4876-9E27-DD2AF58F3EAAQ36557694-F1F58309-13D2-410E-BFEE-0551280A9BDBQ37012197-2E9F0F6D-941E-4726-B8F7-765EF5AC59D0Q37057061-62E41FBA-AE15-4DDF-9A1D-A9FF9F207A38Q37347066-3EC570B6-B6EB-40EB-BAFF-89E4D4863857Q37451228-4DE0936B-02BC-472A-8FBB-CB846C1183D2Q37494942-8B617B01-3DD6-42E7-8212-34234405E190Q38204363-245C8CDC-73F6-4FAD-AD1E-1E41A083139DQ38208244-E0CCE6B7-21CE-4253-949C-6533E7C857EBQ38209841-9B59C7E8-D3D3-4CD3-A036-3CCF7B92E387Q38266325-2C0743FD-4D25-4B12-8369-ABED594C320EQ38399184-6B95AB40-E508-4ED0-840E-BB6ACE1E3F2CQ38406157-49C27454-0B66-4369-B685-956477A18E67Q38531919-BAEF2D11-4156-42F6-8238-E4CDB104819DQ38571581-74886D74-A8DA-47DA-98CC-E1811381BC1DQ38946604-5D5CFD04-9F59-4102-94DB-0FFE16045A58Q40598255-E142CB91-4299-4068-AF9D-E0FC4DD86C25Q41231506-4FF8374F-6F68-49BF-A288-5CF4C3C06CFBQ41400495-1D551DEC-4226-453B-B6DF-CD410782B1F9Q42362579-FE69A629-F56B-4D54-AF73-89F439BFF6FEQ42384700-BF4FA6CB-B4AF-4FA5-AB7E-9F4D70246790Q47661714-B948C323-33A1-4B72-937D-C7E83FEC1180Q47962475-58BCB176-6349-442B-B4CE-C963C728D4CD
P2860
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
@ast
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
@en
type
label
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
@ast
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
@en
prefLabel
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
@ast
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
@en
P2860
P1476
The role of bronchodilator treatment in the prevention of exacerbations of COPD.
@en
P2093
Jadwiga A Wedzicha
Terence A R Seemungal
P2860
P304
P356
10.1183/09031936.00048912
P577
2012-07-26T00:00:00Z